Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin ® ) in paediatric patients under 6 years of age with severe von Willebrand disease.
Blood transfusion = Trasfusione del sangue（2023）
摘要
The results show that Wilfactin provides a safe and effective treatment in patients <6 years of age with severe VWD.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要